V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 250001697 | 250004741 | 1.59 | 135 | null | 2019-11-02 | 2019-11-03 | STS Rhabdomyosarcoma RMS 2005 IVA | 02 | N | ATEZOLIZUMAB | 101840571 |
| 250001751 | 250004742 | 1.7 | 131.9 | null | null | 2017-08-15 | CAPECITABINE + OXALIPLATIN | N | N | CARBOPLATIN + PEMETREXED | 101772420 |
| 250001761 | 250004743 | null | null | null | null | 2018-04-10 | CABOZANTINIB | null | null | TRIAL UNSPECIFIED | 100399430 |
| 250002228 | 250004753 | null | null | Palliative (P) | 2018-04-09 | 2018-04-23 | Carboplatin + Paclitaxel (3 weekly) | 02 | N | CARBOPLATIN + PEMETREXED | 101712864 |
| 250002288 | 250004757 | null | null | Palliative (P) | null | 2016-12-02 | Cyclophosphamide + Topotecan | 02 | null | ATEZOLIZUMAB | 101230625 |
| 250002365 | 250004760 | 1.81 | 89.9 | Neo-adjuvant (N) | 2018-07-09 | 2018-07-09 | CAPECITABINE + OXALIPLATIN | 02 | N | STS RHABDOMYOSARCOMA RMS 2005 IVA | 101127926 |
| 250002379 | 250004761 | 1.62 | 61.4 | Curative (C) | 2020-01-09 | 2020-01-14 | Atezolizumab | 01 | N | DOXORUBICIN + IFOSFAMIDE | 100537716 |
| 250002502 | 250004763 | null | null | null | null | 2020-11-18 | Trial Unspecified | null | null | ENZALUTAMIDE | 100633098 |
| 250002511 | 250004764 | 1.69 | 0 | null | 2017-05-20 | 2017-05-21 | STS Rhabdo RMS 2005 Vin Cyclo | 02 | N | TRIAL UNSPECIFIED | 101394687 |
| 250000589 | 250004769 | 1.92 | 12 | null | 2018-08-20 | 2018-08-22 | Trial Unspecified | 02 | N | CARBOPLATIN + PACLITAXEL | 100715046 |
| 250001243 | 250004772 | 1.53 | 94.6 | Neo-adjuvant (N) | 2018-12-13 | 2018-12-26 | null | 02 | null | CARBOPLATIN + FLUOROURACIL | 101824842 |
| 250001724 | 250004774 | 1.87 | 74 | null | 2019-11-14 | 2020-03-09 | CABOZANTINIB | 02 | N | CISPLATIN + CAPECITABINE + EPIRUBICIN | 101871038 |
| 250001761 | 250004775 | 1.76 | 71.3 | null | 2017-08-03 | 2018-05-07 | Irinotecan + Modified De Gramont | 02 | N | CAPECITABINE + IRINOTECAN | 100399430 |
| 250001986 | 250004776 | 1.83 | 10.5 | Palliative (P) | 2018-02-15 | 2018-06-30 | Atezolizumab | 02 | null | ATEZOLIZUMAB | 100407895 |
| 250002429 | 250004778 | null | null | null | null | 2019-09-17 | null | null | null | EW EUROEWING 2012 ARM B VC | 100005118 |
| 250002512 | 250004779 | 1.55 | 59 | Adjuvant (A) | 2019-04-16 | 2019-05-06 | null | 02 | N | CABOZANTINIB | 101653937 |
| 250001761 | 250004780 | 1.88 | 14.7 | 03 | 2018-03-20 | 2018-03-22 | NB HRNBL-1 COJEC Ind COURSE C | 01 | N | CYCLOPHOSPHAMIDE + DOXORUBICIN + VINCRISTINE | 100399430 |
| 250000817 | 250005171 | 1.86 | 89 | Palliative (P) | 2019-09-22 | 2019-11-18 | CARBOPLATIN + GEMCITABINE | 02 | N | CARBOPLATIN + GEMCITABINE | 100496541 |
| 250000818 | 250005172 | 1.62 | 52.8 | null | null | 2017-10-29 | PEMBROLIZUMAB | null | null | PEMBROLIZUMAB | 100070381 |
| 250000825 | 250005174 | 1.62 | 88.7 | Palliative (P) | 2018-06-16 | 2018-06-23 | null | 02 | N | NIVOLUMAB | 100593877 |
| 250000828 | 250005175 | 1.76 | null | null | null | 2018-06-07 | null | null | null | CARBOPLATIN + GEMCITABINE | 101087504 |
| 250000831 | 250005176 | 1.74 | 90 | Neo-adjuvant (N) | 2019-06-09 | 2019-06-26 | PEMBROLIZUMAB | 02 | N | PEMBROLIZUMAB | 100900723 |
| 250000835 | 250005177 | 1.66 | 62.4 | null | null | 2019-06-23 | PEMBROLIZUMAB | null | null | PEMBROLIZUMAB | 100055772 |
| 250000839 | 250005178 | 1.72 | 128 | Palliative (P) | 2019-09-06 | 2019-10-05 | null | 02 | null | CARBOPLATIN + GEMCITABINE | 101096005 |
| 250000841 | 250005179 | 1.69 | 89 | Palliative (P) | 2019-02-08 | 2019-02-08 | null | 02 | N | NIVOLUMAB | 100315408 |
| 250000844 | 250005180 | 1.64 | 93.6 | null | 2021-03-20 | 2021-03-24 | null | 02 | null | CARBOPLATIN + GEMCITABINE | 101142228 |
| 250000850 | 250005183 | 1.73 | 64.9 | null | null | 2018-10-09 | CISPLATIN + GEMCITABINE | null | null | CISPLATIN + GEMCITABINE | 100578954 |
| 250000852 | 250005185 | 1.66 | 67 | null | null | 2018-09-14 | PEMBROLIZUMAB | null | null | PEMBROLIZUMAB | 101098737 |
| 250000853 | 250005186 | 1.69 | null | null | 2017-05-09 | 2017-11-03 | null | 02 | null | CISPLATIN + GEMCITABINE | 101821483 |
| 250000856 | 250005187 | 1.87 | 52.5 | null | null | 2018-07-29 | PEMBROLIZUMAB | null | null | PEMBROLIZUMAB | 100659191 |
| 250000857 | 250005188 | 1.75 | 58 | null | null | 2019-02-14 | CISPLATIN + GEMCITABINE | null | null | NIVOLUMAB | 101297144 |
| 250000867 | 250005190 | 1.76 | 66.9 | null | null | 2020-10-30 | GemCarbo Days 1+8 | null | null | CARBOPLATIN + GEMCITABINE | 100586650 |
| 250000873 | 250005192 | 1.41 | 77.1 | null | null | 2021-12-07 | null | null | null | NIVOLUMAB | 100817815 |
| 250000875 | 250005193 | 1.67 | 74.5 | null | null | 2017-08-05 | Cisplatin + Gemcitabine (D 1 & 8) | null | null | NIVOLUMAB | 101505369 |
| 250000876 | 250005194 | 1.67 | 64.2 | null | null | 2019-11-22 | null | null | null | CARBOPLATIN + GEMCITABINE | 101489743 |
| 250000877 | 250005195 | 1.72 | 70 | null | null | 2018-07-21 | CISPLATIN + GEMCITABINE | null | null | NIVOLUMAB | 101602119 |
| 250000881 | 250005197 | 1.78 | 55.3 | Palliative (P) | 2019-07-27 | 2019-07-28 | null | 02 | N | PEMBROLIZUMAB | 101716724 |
| 250000882 | 250005198 | 1.73 | 100.95 | null | null | 2019-12-13 | null | null | null | CARBOPLATIN + GEMCITABINE | 100712496 |
| 250000883 | 250005199 | 1.63 | 63.9 | Palliative (P) | 2018-11-17 | 2018-11-23 | null | 02 | N | CISPLATIN + GEMCITABINE | 101300707 |
| 250000884 | 250005200 | 1.65 | 87 | null | null | 2018-01-30 | CARBOPLATIN + GEMCITABINE | null | null | CARBOPLATIN + GEMCITABINE | 100584483 |
| 250000887 | 250005201 | 1.64 | 138 | null | null | 2017-12-04 | Cisplatin + Gemcitabine (D 1 & 8) | null | null | CISPLATIN + GEMCITABINE | 100351905 |
| 250000892 | 250005204 | 1.76 | 70 | null | null | 2017-07-02 | null | null | null | CISPLATIN + GEMCITABINE | 100818238 |
| 250000895 | 250005205 | 1.57 | 63 | null | null | 2017-01-23 | null | null | null | CARBOPLATIN + GEMCITABINE | 100644909 |
| 250000896 | 250005206 | 0 | 0 | null | null | 2021-09-20 | PEMBROLIZUMAB | null | null | PEMBROLIZUMAB | 101156472 |
| 250000897 | 250005207 | 1.71 | 96.4 | null | null | 2019-02-22 | CARBOPLATIN + GEMCITABINE | null | null | CARBOPLATIN + GEMCITABINE | 100413817 |
| 250000899 | 250005208 | 1.48 | 75 | null | null | 2017-03-29 | CISPLATIN + GEMCITABINE | null | null | NIVOLUMAB | 100327438 |
| 250000900 | 250005209 | 1.9 | 61.7 | null | null | 2019-08-21 | PEMBROLIZUMAB | null | null | PEMBROLIZUMAB | 100111260 |
| 250000902 | 250005210 | 1.65 | 80 | null | null | 2019-03-20 | null | null | null | CARBOPLATIN + GEMCITABINE | 101728404 |
| 250000905 | 250005211 | 1.7 | 92.8 | null | null | 2019-08-03 | null | null | null | CARBOPLATIN + GEMCITABINE | 101064002 |
| 250000907 | 250005212 | 1.8 | 94.2 | null | null | 2017-10-06 | CISPLATIN + GEMCITABINE | null | null | CISPLATIN + GEMCITABINE | 100206727 |